We are live on ! Find out more

12 hedge funds and large institutions have $12.8M invested in BiomX in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

22% more capital invested

Capital invested by funds: $10.5M → $12.8M (+$2.27M)

0% more ownership

Funds ownership: 0.12%0.12% (+0%)

8% less funds holding

Funds holding: 1312 (-1)

33% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 3

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
12
Holders Change
-1
Holders Change %
-7.69%
% of All Funds
0.19%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
2
Increased
1
Reduced
4
Closed
3
Calls
$22K
Puts
Net Calls
+$22K
Net Calls Change
+$7K

PHGE Hedge Fund Activity: Q1 2022 in Review

12 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in BiomX (PHGE) for Q1 2022, worth a combined $12.8M — up 22% from $10.5M a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of PHGE and 2 opened new positions — a net loss of 1 holder — while 4 trimmed existing stakes and 1 added.

The largest buyer was Royce & Associates, adding an estimated $335K. The largest seller was Millennium Management, cutting an estimated $99.9K.

  • 12 institutional investors held BiomX (PHGE) as of Q1 2022, down from 13 in Q4 2021.
  • Funds reported $12.8M of BiomX stock for Q1 2022, up 22% quarter-over-quarter.
  • 2 funds opened new BiomX positions in Q1 2022 and 3 closed out, a net change of -1 holder.
  • The largest BiomX buyer in Q1 2022 was Royce & Associates, an estimated $335K added.
  • The largest BiomX seller in Q1 2022 was Millennium Management, an estimated $99.9K sold.

Based on aggregated 13F filings for Q1 2022.